March 13, 2018
The ADDF announces two investments in programs targeting mitochondria and the progranulin gene.
March 7, 2017
We recently awarded eight new grants totaling over $4 million to advance treatments for Alzheimer’s and related dementias. Several of the awards support new approaches to treating these diseases.
September 12, 2016
The ADDF awarded three new grants in July and August for potential new treatments for Alzheimer's and other dementias.
February 27, 2014
The ADDF and the Foundation for Mitochondrial Medicine awarded $200,000 to James Bennett, M.D., Ph.D. to further research gene therapy of mitochondrial protein in mice with experimental Alzheimer's disease.
© Copyright 2024. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).